SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (NASDAQ:VTYX) ("Ventyx"), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in the following upcoming investor conferences:
- Event: UBS Obesity Therapeutics Day
Location: Virtual
Date: Thursday, May 23, 2024
Time: 12:00-12:30 PM ET
- Event: Jefferies Global Healthcare Conference
Location: New York, NY
Date: Thursday, June 6, ...